OH AND I HAVE BEEN SLOWLY PICKING UP LITTLE PARCELS OF MNM'S FINEST... NOTHING LIKE AVERAGING DOWN ON A QUALITY STOCK I SAY..
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%